Statnick M A, Schober D A, Gehlert D R
Lilly Research Laboratories. Eli Lilly and Company, Indianapolis, IN 46285, USA.
Eur J Pharmacol. 1997 Aug 13;332(3):299-305. doi: 10.1016/s0014-2999(97)01031-5.
Recently, we found abundant mRNA and binding sites for neuropeptide Y Y1-like receptors in the human cerebral cortex. However, an earlier study using indirect labeling methods failed to detect substantial neuropeptide Y1-like receptor binding in numerous areas of the human brain, including the cerebral cortex. To resolve the disparity in these findings, we characterized the neuropeptide Y receptor subtypes labeled with [125I]peptide YY in homogenates of human frontal cortex. Competition experiments using 100 pM [125I]peptide YY binding to human frontal cortex homogenates indicated predominantly neuropeptide Y Y2 receptors are labeled with this concentration of ligand. However, saturation analysis of [125I]peptide YY binding to frontal cortex membranes resulted in isotherms best characterized by a two-site fit. Binding of [125I]peptide YY to the high affinity (Kd = 40 pM) binding site was prevented using a 100 nM concentration of the neuropeptide Y Y2 receptor agonist peptide YY-(3-36). By masking the higher affinity site, we found a low affinity [125I]peptide YY binding site (Kd = 1.4 nM) exhibiting a pharmacology consistent with a neuropeptide Y Y1-like receptor. It appears that neuropeptide Y Y2 receptors are the predominant subtype labeled with low concentrations of[125I]peptide YY and that the neuropeptide Y Y1 receptor is a low affinity [125I]peptide YY binding site in the human frontal cortex.
最近,我们在人类大脑皮层中发现了丰富的神经肽Y Y1样受体的mRNA和结合位点。然而,一项早期使用间接标记方法的研究未能在包括大脑皮层在内的人类大脑多个区域检测到大量的神经肽Y1样受体结合。为了解决这些研究结果之间的差异,我们对用[125I]肽YY标记的人类额叶皮层匀浆中的神经肽Y受体亚型进行了表征。使用100 pM [125I]肽YY与人额叶皮层匀浆结合的竞争实验表明,主要是神经肽Y Y2受体被这种浓度的配体标记。然而,[125I]肽YY与额叶皮层膜结合的饱和分析得出的等温线最适合用双位点拟合来表征。使用100 nM浓度的神经肽Y Y2受体激动剂肽YY-(3-36)可阻止[125I]肽YY与高亲和力(Kd = 40 pM)结合位点的结合。通过掩盖较高亲和力的位点,我们发现了一个低亲和力的[125I]肽YY结合位点(Kd = 1.4 nM),其药理学特性与神经肽Y Y1样受体一致。看来神经肽Y Y2受体是被低浓度[125I]肽YY标记的主要亚型,而神经肽Y Y1受体是人类额叶皮层中一个低亲和力的[125I]肽YY结合位点。